News from Zyme and the companies we work with.
Astrea Bioseparations introduces Nereus LentiHERO, a fit-for-purpose solution for lentiviral vector purification
First commercially available product to utilize AstreAdept, Astrea Bioseparations’ novel nanofiber-based membrane material Cambridge, UK, 29 September 2022: Astrea Bioseparations (“Astrea Bio”), a leading provider of novel purification and separation [...]
Yourgene Health Receives HSA approval for IONA Nx NIPT Workflow in Singapore
IVD prenatal screening workflow to help improve access to non-invasive genetic screening for patients and clinicians Company continues to expand global access to products as it scales up revenue opportunities [...]
H.E.L Group strengthens leadership team to focus on new product development and enhanced customer support
Alan Lockley joins as Director of Global Services, Edward Quinn as Director of Product Development and Mark Appleton takes new role as Director of Research London, UK, 6 September 2022: [...]
PhoreMost enters multi-project drug target discovery collaboration with Roche
PhoreMost to deploy its SITESEEKER platform to identify novel targets for Roche’s discovery programmes Cambridge, UK, 06 September 2022: PhoreMost Ltd., the UK-based biopharmaceutical company dedicated to ‘Drugging the Undruggable®’ [...]
Avacta announces AVA6000 receives Orphan Drug Designation from the US Food and Drug Administration
London and Wetherby, UK, 05 September 2022: Avacta Group plc (AIM: AVCT), a clinical stage oncology drug company and developer of powerful diagnostics based on its innovative Affimer® and pre|CISION™ [...]
Global Access Diagnostics acquires manufacturing rights for IT-LEISH rapid diagnostic test from Bio-Rad Laboratories
IT-LEISH is widely used to support the diagnosis of visceral leishmaniasis, a neglected tropical disease Technology transfer to GADx aims to keep vital test accessible on the market Bedford, UK, [...]
Avacta announces Phase I clinical study of AVA6000 to advance to the fourth cohort
London and Wetherby, UK, 01 September 2022: Avacta Group plc (AIM: AVCT), a clinical stage oncology drug company and developer of powerful diagnostics based on its innovative Affimer® and pre|CISION™ [...]
Bio-Rad Introduces Anti-Evolocumab Antibodies for Use in Preclinical and Clinical Drug Development
HERCULES, Calif. — August 25, 2022 — Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, today introduced a range of [...]
Evonetix commences early access program for DNA synthesised by thermal control on its semiconductor chip
Researchers are invited to apply to receive DNA that has been synthesised using Evonetix’s platform Cambridge, UK 16th August 2022– EVONETIX LTD (‘Evonetix’), the synthetic biology company bringing semiconductor technology [...]
Bio-Rad Extends Range of StarBright Violet and UltraViolet Dyes for Multiplex Flow Cytometry
StarBright Violet 760, StarBright UltraViolet 575, and StarBright UltraViolet 605 Dyes Conjugated to Highly Validated Antibodies for Multicolor Panel Design in Immunology Research HERCULES, Calif. — August 10, 2022 — [...]
CrestOptics’ DeepSIM super resolution confocal microscope module named by Microscopy Today as a Top 10 Best Microscopy Innovation of 2022
Innovation awards announced at 2022 Microscopy & Microanalysis Meeting, Portland, Oregon, 31st July – 4th August, 2022 Rome, IT, 01 August, 2022: CrestOptics S.p.A., a manufacturer of high-end microscopy solutions [...]
FUJIFILM Irvine Scientific Launches Heavy Oil for Embryo Culture: Optimized Protection for the IVF Laboratory
Offering ideal handling viscosity with added confidence from rigorous testing procedures SANTA ANA, Calif., July 26, 2022-- FUJIFILM Irvine Scientific, Inc., a world leader in the innovation, development, and manufacture [...]
